The IMI project held its 5th General Assembly Oct 27-28 2022 in Barcelona.
For ITTM Dr. Adriano Barbosa attended and presented our work.
After so many remote meetings, it was great to see all colleagues and partners again. There were good and fruitful discussions on many aspects and in the end, all are looking forward to meeting again – in person – very soon!
The TransBioLine project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 821283 with EU Horizon 2020 and EFPIA support.